A case of anaplastic clear-cell ependymoma presenting with high erythropoietin concentration and 1p/19q deletions

被引:2
|
作者
Asano, Kenichiro [1 ]
Kudo, Kanae [1 ]
Mori, Fumiaki [2 ]
Ohkuma, Hiroki [1 ]
Wakabayashi, Koichi [2 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Neurosurg, Aomori 0368562, Japan
[2] Hirosaki Univ, Grad Sch Med, Dept Neuropathol, Inst Brain Sci, Hirosaki, Aomori, Japan
关键词
Anaplastic clear-cell ependymoma; Erythropoietin; 1p/19q deletions; LEPTOMENINGEAL HEMANGIOBLASTOMA; EXPRESSION; RECEPTOR; TUMORS; IMMUNOREACTIVITY; PATTERNS; SURVIVAL; GRADE;
D O I
10.1007/s10014-011-0043-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We describe a 19-year-old woman with onset of epileptic seizure, and a small mural nodule and multicystic lesions with severe brain edema located in the right frontal lobe. At surgery, the tumor and a clear margin was removed, and symptoms improved postoperatively. Extended local radiotherapy (60 Gy) was performed. Histopathological examination revealed oligodendroglioma-like tumor cells with a perinuclear halo. The tumor cells extended processes toward CD34-positive proliferating vessels, which resemble a basement membrane. These proliferating vessels formed a tumor membrane so that there was a clear margin between the tumor and brain tissue. Tumor cells were positive for epithelial membrane antigen in a dot-like pattern. MIB-1 staining index was 50.6%. Electron microscopy showed cilia and zipper-like junctions, and anaplastic clear-cell ependymoma grade III was diagnosed. A characteristic of the case was formation of a tumor membrane by proliferating tumor blood vessels. Fluorescence in situ hybridization showed 1p/19q deletions, and the concentration of erythropoietin in the cyst fluid was abnormally high, at 1,859.4 mIU/ml. Erythropoietin and erythropoietin receptors were verified with immunohistochemical staining.
引用
收藏
页码:317 / 327
页数:11
相关论文
共 50 条
  • [31] Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma
    Zhao, Binghao
    Ma, Wenbin
    LANCET ONCOLOGY, 2021, 22 (08): : E345 - E345
  • [32] Oligodendrogliomas: relation of morphology to 1p/19q genotype
    An, S.
    Henriquez, N.
    Puls, F.
    Brandner, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 11 - 12
  • [33] Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
    Gadji, Macoura
    Fortin, David
    Tsanaclis, Ana-Maria
    Drouin, Regen
    CANCER GENETICS AND CYTOGENETICS, 2009, 194 (01) : 12 - 22
  • [34] Recurrent oligodendroglioma with changed 1p/19q status
    Barresi, Valeria
    Mafficini, Andrea
    Calicchia, Martina
    Piredda, Maria Liliana
    Musumeci, Angelo
    Ghimenton, Claudio
    Scarpa, Aldo
    NEUROPATHOLOGY, 2022, 42 (02) : 160 - 166
  • [35] PDGFR-a in 1p/19q LOH oligodendrogliomas
    Hartmann, C
    Xu, XD
    Bartels, G
    Holtkamp, N
    Gonzales, IA
    Tallen, G
    Von Deimling, A
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) : 1081 - 1082
  • [36] Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas
    Alentorn, Agusti
    Dehais, Caroline
    Ducray, Francois
    Carpentier, Catherine
    Mokhtari, Karima
    Figarella-Branger, Dominique
    Chinot, Olivier
    Cohen-Moyal, Elisabeth
    Ramirez, Carole
    Loiseau, Hugues
    Elouahdani-Hamdi, Selma
    Beauchesne, Patrick
    Langlois, Olivier
    Desenclos, Christine
    Guillamo, Jean-Sebastien
    Dam-Hieu, Phong
    Ghiringhelli, Francois
    Colin, Philippe
    Godard, Joel
    Parker, Fabrice
    Dhermain, Frederic
    Carpentier, Antoine F.
    Frenel, Jean-Sebastien
    Menei, Philippe
    Bauchet, Luc
    Faillot, Thierry
    Fesneau, Melanie
    Fontaine, Denys
    Motuo-Fotso, Marie-Jeannette
    Vauleon, Elodie
    Gaultier, Claude
    Le Guerinel, Caroline
    Gueye, Edouard-Marcel
    Noel, Georges
    Desse, Nicolas
    Durando, Xavier
    Barrascout, Eduardo
    Wager, Michel
    Ricard, Damien
    Carpiuc, Ioana
    Delattre, Jean-Yves
    Idbaih, Ahmed
    NEUROLOGY, 2015, 85 (15) : 1325 - 1331
  • [37] High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors
    Adam Wu
    Kenneth Aldape
    Frederick F. Lang
    Journal of Neuro-Oncology, 2010, 99 : 57 - 64
  • [38] Assessment of the 1p/19q Deletions at Different Areas in Biphasic Oligoastrocytomas by Using Chromogenic In Situ Hybridization
    Oliveira, V. C.
    Carrara, R. C. V.
    Covas, D. T.
    Latorraca, E. F.
    Carlotti, C. G.
    Colli, B. O.
    Machado, H. R.
    Neder, L.
    LABORATORY INVESTIGATION, 2009, 89 : 333A - 333A
  • [39] MOLECULAR-GENETIC ANALYSIS OF OLIGODENDROGLIAL TUMORS SHOWS PREFERENTIAL ALLELIC DELETIONS ON 19Q AND 1P
    REIFENBERGER, J
    REIFENBERGER, G
    LIU, L
    JAMES, CD
    WECHSLER, W
    COLLINS, VP
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (05): : 1175 - 1190
  • [40] Screening Method to Detect 1p/19q Co-Deletions by Targeted Next Generation Sequencing
    Zomorrodian, Sina
    Mayigowda, Pramod
    Hu, Lan
    Buckley, Alexa
    Marchenko, Olena
    Dimitrova, Nevenka
    Fallon, John T.
    Ye, Fei
    Zhong, Minghao
    MODERN PATHOLOGY, 2019, 32